Back to Search
ANDREW MUTNICK, MD
MD
Pediatrics Physician
NPI: 1578593851Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
227307(NY)
Research & Publications (20)
Pharmacist- versus physician-obtained medication histories.
PMID 18436732·Am J Health Syst Pharm·2008
4-observational
Implementing guidelines for the institutional use of factor VIIa (recombinant): a multidisciplinary solution.
PMID 16914635·Am J Health Syst Pharm·2006
8-other
Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).
PMID 14711839·J Antimicrob Chemother·2004
8-other
Antimicrobial activity of LB10827, a new orally administered cephalosporin, tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.
PMID 14616716·Clin Microbiol Infect·2003
8-other
Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002).
PMID 14596971·Diagn Microbiol Infect Dis·2003
4-observational
Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program.
PMID 12773059·Ann Pharmacother·2003
4-observational
Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997-2000).
PMID 12742321·Diagn Microbiol Infect Dis·2003
8-other
Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000).
PMID 12730001·Diagn Microbiol Infect Dis·2003
4-observational
Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000).
PMID 12730000·Diagn Microbiol Infect Dis·2003
4-observational
A cost-effectiveness analysis of stress ulcer prophylaxis.
PMID 12708935·Ann Pharmacother·2003
3-trial
CANCER resistance surveillance program: initial results from hematology-oncology centers in North America. Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance.
PMID 12503932·Ann Pharmacother·2003
4-observational
In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci.
PMID 12461013·J Antimicrob Chemother·2002
8-other
Impact of modified nonmeningeal Streptococcus pneumoniae interpretive criteria (NCCLS M100-S12) on the susceptibility patterns of five parenteral cephalosporins: report from the SENTRY antimicrobial surveillance program (1997 to 2001).
PMID 12409423·J Clin Microbiol·2002
8-other
Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000).
PMID 12151191·Diagn Microbiol Infect Dis·2002
8-other
Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection.
PMID 12120879·J Chemother·2002
8-other
Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000).
PMID 12088624·Diagn Microbiol Infect Dis·2002
8-other
Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998-2000.
PMID 12052631·Diagn Microbiol Infect Dis·2002
4-observational
A cost-benefit analysis of RSV prophylaxis in high-risk infants.
PMID 11675842·Ann Pharmacother·2001
8-other
Evaluation of antimicrobial surgical prophylaxis with multiattribute utility theory.
PMID 11217182·Am J Health Syst Pharm·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3959 BROADWAY, COLUMBIA UNIVERSITY DEPARTMENT PEDIATRICS
NEW YORK, NY 10032 - Phone
- (212) 304-7250
Quick Facts
- NPI
- 1578593851
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile